Thomas McLean to Vincristine
This is a "connection" page, showing publications Thomas McLean has written about Vincristine.
Connection Strength
0.286
-
Russell TB, Rinker EK, Dillingham CS, Givner LB, McLean TW. Pneumocystis Jirovecii Pneumonia During Sirolimus Therapy for Kaposiform Hemangioendothelioma. Pediatrics. 2018 04; 141(Suppl 5):S421-S424.
Score: 0.141
-
Borst AJ, Eng W, Griffin M, Ricci KW, Engel E, Adams DM, Dayneka J, Cohen-Cutler SJ, Andreoli SM, Wu MD, Wheeler AP, Heym KM, Crary SE, Nakano TA, Schulte RR, Setty BA, McLean TW, Pahl KS, Intzes S, Pateva I, Teitelbaum M, Zong Z, Li Y, Jeng MR. Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study. Pediatr Blood Cancer. 2024 Mar; 71(3):e30779.
Score: 0.052
-
McLean TW. Medulloblastomas and central nervous system primitive neuroectodermal tumors. Curr Treat Options Oncol. 2003 Dec; 4(6):499-508.
Score: 0.052
-
McLean TW, Hertel C, Young ML, Marcus K, Schizer MA, Gebhardt M, Weinstein HJ, Perez-Atayde A, Grier HE. Late events in pediatric patients with Ewing sarcoma/primitive neuroectodermal tumor of bone: the Dana-Farber Cancer Institute/Children's Hospital experience. J Pediatr Hematol Oncol. 1999 Nov-Dec; 21(6):486-93.
Score: 0.039